We wished to better define the role, if any, of Wnt signalling in HSC specification during embryonic development. Although Wnt signalling can exert strong effects on adult HSCs, an *in vivo* regulatory function is controversial, and the role of Wnt signalling in establishing haematopoiesis during development is unclear^[@R2]^. Wnt signalling pathways have been loosely grouped into two families, "canonical" and "noncanonical"^[@R2],\ [@R3]^. Canonical signalling is defined by stabilization of β-catenin, which in cooperation with lymphoid-enhancer-binding factor/T cell factor (Lef/Tcf) DNA-binding proteins, activates transcription of Wnt target genes^[@R2],\ [@R3]^. Non-canonical signalling is β-catenin/Tcf-independent, with less well characterized intracellular pathways^[@R3]^. Disruption of canonical signalling by targeted deletion of *Wnt3a* results in HSC deficits^[@R2]^, but these animals have massive morphological defects, including near absence of the caudal tissues^[@R4]^ where HSCs arise during embryogenesis. Canonical Wnt signalling by unknown ligands also appears to play a role in maintaining and/or expanding very early HSCs in cooperation with prostaglandins^[@R5]^. At present, no studies have demonstrated an absolute requirement for Wnt signalling in the earliest specification of recognizable HSCs, and no requirement for β-catenin/Tcf-independent, non-canonical signalling has been reported.

We searched for candidate Wnts expressed near prehaematopoietic mesoderm and identified a previously uncharacterized zebrafish *wnt16* orthologue ([Fig. S1](#SD1){ref-type="supplementary-material"}) expressed in the dorsoanterior portion of more rostral somites from 10 hours post-fertilization (hpf; tailbud-stage) to 24 hpf ([Fig. S2](#SD1){ref-type="supplementary-material"}), the time frame when prehaematopoietic mesoderm transitions to recognizable HSC precursors in the dorsal aorta. *Wnt16* is conserved across vertebrate phyla ([Fig. S1](#SD1){ref-type="supplementary-material"}), and the human form was originally identified as a gene inappropriately expressed in pre-B-acute lymphoblastic leukaemia (ALL) cells containing the E2A-PBX1 t(1;19) translocation product^[@R6]^. In zebrafish, two *wnt16* splice variants are produced, only one of which is active ([Fig. S1, a, b; Fig. S3; Table S1](#SD1){ref-type="supplementary-material"}).

Knock down of Wnt16 by injection of either of two "splice-blocking" morpholinos caused a striking haematopoietic phenotype. Morpholinos alone or in combination reduced functional *wnt16* message ([Figs. S1, a; S4](#SD1){ref-type="supplementary-material"}), yielding highly similar phenotypes in comparison to a 5-basepair mismatch control morpholino, which had no effect. ([Figs. S4, S5](#SD1){ref-type="supplementary-material"}). HSC precursors, a population of *runx1*^+^ cells in the ventral floor of the dorsal aorta^[@R1],\ [@R7],\ [@R8]^, as in mouse^[@R9]^, are absent in embryos injected with W16MO at 24 hpf by whole mount in situ hybridization (WISH; red arrowhead; [Fig. 1 a, b](#F1){ref-type="fig"}; [Table S2](#SD1){ref-type="supplementary-material"}). By 33 hpf, HSCs can be observed as a population of *cmyb*^+^ cells between the dorsal aorta and posterior cardinal vein^[@R1]^, and this population is also absent (red arrowhead, [Fig. 1 c, d](#F1){ref-type="fig"}; [Table S2](#SD1){ref-type="supplementary-material"}). HSCs observable in living transgenic animals carrying *GFP* under the control of the *cd41* (*itga2b*) promoter^[@R10]-[@R12]^ are absent or reduced in *wnt16* morphants (red arrowheads, [Fig. 1 e, f](#F1){ref-type="fig"}; [Movies S1 and S2; Table S2](#SD1){ref-type="supplementary-material"}), as are unique double-positive cells in *kdrl:RFP* and *cmyb:GFP* double transgenics^[@R7]^ ([Fig. 1 g, h, yellow cells](#F1){ref-type="fig"}; [Table S2](#SD1){ref-type="supplementary-material"}), whereas unrelated GFP-labelled multi-ciliate cells in the pronephros are unaffected (yellow arrowheads, [Fig. 1 e, f; green cells, Fig. 1 g, h](#F1){ref-type="fig"}). Generation of T-lymphocytes requires an HSC precursor^[@R10],\ [@R11],\ [@R13]^, providing a useful readout for whether HSCs have been specified or not. In *cd41:GFP* transgenic animals, GFP^+^ HSCs retain residual fluorescence as they differentiate into the first thymic lymphocytes around 3 days post fertilization (dpf)^[@R10]^, and these thymic immigrants are greatly reduced in *wnt16* morphants ([Movies S3 and S4](#SD1){ref-type="supplementary-material"}). Accordingly, *wnt16* morphants lack *rag1*^+^ T lymphocytes at 4.5 dpf (blue arrows, [Fig. 1, i, j](#F1){ref-type="fig"}; [Table S2](#SD1){ref-type="supplementary-material"}), despite intact thymic epithelium ([Fig. S6](#SD1){ref-type="supplementary-material"}). Together, our results indicate that Wnt16 is required for specification of HSCs during embryonic development.

To determine the specificity of W16MO-induced defects, we examined the integrity of non-hematopoietic tissues by morphology and expression of marker genes ([Fig. 2](#F2){ref-type="fig"}; [Table S3](#SD1){ref-type="supplementary-material"}). *Wnt16* morphants are grossly normal ([Fig. 2 a, b](#F2){ref-type="fig"}), with intact and functional vasculature, as evidenced by beating hearts and circulating primitive, non-HSC-derived erythroid cells, although there appear to be subtle patterning defects in the number and position of intersegmental vessels. By WISH, W16MO-injected embryos have primitive blood (*gata1*; [Fig. 2 c, d](#F2){ref-type="fig"}; [Table S3](#SD1){ref-type="supplementary-material"}), somites (*myod*; [Fig. 2 e, f](#F2){ref-type="fig"}; [Table S3](#SD1){ref-type="supplementary-material"}), vasculature (*tll1, cdh5*, and *flk1*; [Fig. 2 g-l](#F2){ref-type="fig"}; [Table S3](#SD1){ref-type="supplementary-material"}), dorsal aorta (*efnb2a*; [Fig. 2 m, n](#F2){ref-type="fig"}; *notch1b, notch3, dll4* [Fig. S7, a-d, o, p; Tables S3, S5](#SD1){ref-type="supplementary-material"}), hypochord (*col2a1a*; [Fig. 2 o, p](#F2){ref-type="fig"}; [Table S3](#SD1){ref-type="supplementary-material"}), notochord and floorplate (*shha*; [Fig. 2 q, r](#F2){ref-type="fig"}; [Table S3](#SD1){ref-type="supplementary-material"}), and pronephros (*cdh17*; [Fig. 2 s, t](#F2){ref-type="fig"}; [Table S3](#SD1){ref-type="supplementary-material"}). Thus, defects in HSC specification in *wnt16* morphant animals are highly specific and not due to wholesale failure in specification of nearby tissues.

Canonical, β-catenin/Tcf-dependent Wnt signalling has been reported to be involved in HSC specification in mouse^[@R2]^ and very early maintenance in zebrafish^[@R5]^. We therefore wanted to determine if Wnt16 is canonical. Overexpression of Wnt16 caused phenotypic defects demonstrating active protein ([Fig. S3](#SD1){ref-type="supplementary-material"}), but in comparison to Wnt3^[@R14]^, did not cause ectopic expression of canonical targets ([Fig. S8](#SD1){ref-type="supplementary-material"}). Conversely, Wnt16 knock down caused no decrease in canonical reporter activity ([Fig. S9](#SD1){ref-type="supplementary-material"}). Thus, Wnt16 does not act via β-catenin/Tcf and must act via a non-canonical pathway as has been suggested for human WNT16b^[@R15],\ [@R16]^. Loss of other non-canonical Wnt ligands causes distinct phenotypes. Loss of Wnt5b is much more severe causing nearly complete absence of primary trunk vasculature^[@R17]^, whereas loss of Wnt11 had no effects on HSC specification ([Fig. S10, Table S4](#SD1){ref-type="supplementary-material"}). We therefore conclude that the HSC defects caused by loss of *wnt16* are not a general consequence of loss of non-canonical Wnt signalling.

Notch signalling is required across phyla for developmental specification of HSCs^[@R1]^. Global inhibition of Notch signalling by mutation or targeted deletion of *Mindbomb* (*Mib*), which is required for Notch ligand activity, or the essential Notch DNA-binding co-factor *Rbpjκ* results in total loss of HSCs, as well as severe vascular defects^[@R1]^. If Wnt16 were to regulate Notch pathway genes, this regulation might explain the loss of HSCs in *wnt16* morphant animals. The specific ligands and receptors required in zebrafish for specification of HSCs by the Notch pathway have not been determined. We therefore examined comparative expression of Notch ligands and receptors that might participate in HSC specification in uninjected or W16MO-injected animals. Most Notch receptors and ligands were either unaffected or very weakly affected ([Fig. S7](#SD1){ref-type="supplementary-material"}; [Fig. 4 c,d](#F4){ref-type="fig"}; [Table S5](#SD1){ref-type="supplementary-material"}). However, expression of two Notch ligands, *dlc* and *dld*, was markedly decreased in somites at 17 hpf (16-ss; [Fig. 3 a-d](#F3){ref-type="fig"}, [Table S5](#SD1){ref-type="supplementary-material"}). In accord with decreased somitic ligand expression, Notch reporter activity was decreased in somites at 17.5 hpf ([Fig. S11](#SD1){ref-type="supplementary-material"}). Interestingly, diminution of *dlc* and *dld* was tissue-specific, because expression was maintained in presomitic mesoderm ([Fig. 4 a-d](#F4){ref-type="fig"}), and *dlc* expression in the dorsal aorta appeared relatively normal at 22 hpf ([Fig. S12, Table S5](#SD1){ref-type="supplementary-material"}). Although Wnt16 function is required for somitic expression of *dlc* and *dld*, we see no evidence for reciprocal regulation of *wnt16* by Dlc and Dld ([Fig. S13](#SD1){ref-type="supplementary-material"}), or indeed by Notch at all, as expression is unaffected in *mib* mutants (not shown).

To determine whether alterations in the expression of *dlc* and/or *dld* might explain the decrease in HSCs we observe in *wnt16* morphant animals, we tested whether loss of function in these genes alone or in combination could alter HSC specification. *Beamter* (*bea*) mutants carry a predicted null allele of *dlc*^[@R18]^. We compared HSC and T lymphocyte marker expression in wild-type embryos, homozygous *bea* mutants, embryos injected with *dld* morpholino (dldMO)^[@R19]^, and homozygous *bea* mutants injected with dldMO. We found that *runx1* transcripts at 24 hpf, and *cmyb* at 36 hpf, were greatly reduced in *bea* homozygous mutants and embryos injected with dldMO ([Fig. 3, e-g, i-k](#F3){ref-type="fig"}: [Table S6](#SD1){ref-type="supplementary-material"}), but an apparent recovery of HSCs had occurred by 4.5 dpf, when *rag1* transcripts, revealing the thymic progeny of HSCs, were readily visible in both groups ([Fig. 3 m-o](#F3){ref-type="fig"}; [Table S6](#SD1){ref-type="supplementary-material"}). Combinatorial reduction of Dlc and Dld activity, however, eliminated HSCs, as revealed by elimination of *runx1* at 24 hpf ([Fig. 3, h](#F3){ref-type="fig"}; [Table S6](#SD1){ref-type="supplementary-material"}), *cmyb* at 36 hpf ([Fig. 3, l](#F3){ref-type="fig"}; [Table S6](#SD1){ref-type="supplementary-material"}), and *rag1* transcripts at 4.5 dpf ([Fig. 3, p](#F3){ref-type="fig"}, [Table S6](#SD1){ref-type="supplementary-material"}). Thus, *dlc* and *dld* are combinatorially required for specification of HSCs in zebrafish, and their diminished expression in the somites of *wnt16* morphant animals can, in principle, explain the observed loss of HSCs.

To confirm that loss of HSCs in *wnt16* morphants is due to loss of *dlc* and *dld*, we performed a rescue experiment. We injected embryos with W16MO, and in some cases co-injected mRNA encoding full-length Dlc and Dld ligands singly or in combination. Injection of *dlc* and *dld* mRNA did not alone, or in combination have a strong effect on HSC numbers, as measured by *runx1*^+^ cells in the dorsal aorta ([Fig. 3, q-t, y](#F3){ref-type="fig"}). Co-injection of individual mRNAs with W16MO was unable to restore *runx1* in ([Fig. 3, u-w, y](#F3){ref-type="fig"}). However, when injected together, *dlc* and *dld* restored *runx1*^+^ HSCs in a high percentage of W16MO-injected animals ([Fig. 3, x, y](#F3){ref-type="fig"}). These results confirm that decreased *dlc* and *dld* expression in *wnt16* morphants is responsible for loss of HSCs.

Studies in zebrafish and mouse have shown that Notch specification of HSCs is regulated by Shh and VegfA^[@R1]^. Shh regulates expression of *vegfa*, and VegfA signalling is in turn required for vascular expression of Notch receptor genes^[@R1]^. Notch signalling is required for both arteriovenous and HSC specification^[@R1],\ [@R20]-[@R24]^. In accord with these observations, loss of Shh signalling causes loss of both artery and HSCs^[@R1]^. Taken together, one level of control over HSC specification appears to be through a Shh/VegfA/Notch signalling pathway^[@R1]^. Shh/VegfA/Notch specification of HSCs appears to be distinct from Wnt16/Dlc/Dld effects because vascular and arterial specification is unaffected in W16MO animals ([Fig. 2, i-n](#F2){ref-type="fig"}; [Fig. S7, a-d, o, p](#SD1){ref-type="supplementary-material"}). Moreover *shha* and Notch receptor expression are unaffected in W16MO animals ([Fig. 2, q, r](#F2){ref-type="fig"}, [Fig. S7, a-l](#SD1){ref-type="supplementary-material"}). To confirm these pathways are discrete, we examined expression of six known Shh target genes, with particular interest in *vegfaa*. None of the Shh targets examined showed significantly altered expression ([Fig. S14; Table S7](#SD1){ref-type="supplementary-material"}). Our results suggest that the Wnt16 and Shh pathways act in parallel upstream of HSC specification.

The predominant model for how Notch signalling regulates HSC specification is that endothelial cells of the dorsal aorta, receive a requisite Notch1-mediated signal^[@R1],\ [@R21]-[@R24]^. Chimeric mice generated using Notch1-deleted cells show no contribution of knockout cells to the adult haematopoietic system, demonstrating that Notch1 signalling is required cell-autonomously for specification of HSCs^[@R1],\ [@R21]^. The relevant Notch ligand(s) are thought to be expressed in the formed dorsal aorta and/or immediately surrounding mesenchyme^[@R1],\ [@R22]-[@R24]^. A contributing ligand appears to be *Jag1*, because knockout mice have severely impaired, but not totally abrogated development of HSCs^[@R1],\ [@R24]^. Notch1 activation of *Runx1* is thought to occur indirectly through *Gata2*, since the *Runx1* promoter does not contain identifiable *Rbpjκ* binding sites^[@R1],\ [@R21],\ [@R23],\ [@R24]^. Notch signalling defects in *wnt16* morphants suggests that the requirement for Dlc/Dld is not the same as this cell-autonomous requirement, because decreased Notch ligand expression is specific to somites ([Fig. 3, a-d](#F3){ref-type="fig"}), whereas expression of *dlc* is normal in the dorsal aorta of *wnt16* morphants ([Fig. S12, Table S5](#SD1){ref-type="supplementary-material"}) and *dld* is not natively expressed near the formed dorsal aorta. Moreover, expression of *jag1b* and its putative target *gata2* are unaffected in Wnt16 knock down animals ([Fig. 4, a-d](#F4){ref-type="fig"}).

To better understand whether Dlc/Dld specification of HSCs work cell-autonomously or not, we sought to define the timing of the Notch signalling event lacking in W16MO-injected animals using animals carrying transgenes that allow heat-shock induction of the Notch intracellular domain (NICD), which is a dominant activator of the Notch pathway^[@R20],\ [@R25]^. We induced *NICD* expression at different time points to identify the temporal window when enforced Notch activity could rescue HSC expression in *wnt16* morphants. Nuclear, myc-tagged NICD protein is present in transgenic animals by 1 hour post heat shock (hphs), and is strong from 3 hphs ([Fig. 4, e-h](#F4){ref-type="fig"}) through at least 24 hphs (not shown), consistent with prior reports^[@R26]^. Heat-shock induction of *NICD* at 14 hpf (10-ss) rescued *cmyb* expression at 36 hpf ([Fig. 4, i-k](#F4){ref-type="fig"}; [Table S8](#SD1){ref-type="supplementary-material"}), as has been seen previously for rescue of *mib*^[@R20]^. Surprisingly, heat shock just two hours later (14-ss) did not rescue *cmyb* expression along the dosal aorta (red circle, [Fig. 4, l](#F4){ref-type="fig"}, [Table S8](#SD1){ref-type="supplementary-material"}). These results indicate that the critical phase of Notch signalling required for HSC specification downstream of Wnt16, occurs between 15-17 hpf (12-16-ss) and abruptly terminates by about 18-19 hpf (18-20-ss).

Since this timing is well prior to the formation of the dorsal aorta and HSCs from its ventral endothelium, we sought to determine when cells fated to become HSCs first experience a cell-autonomous Notch signal. We first took advantage of a *tp1:Kaede* Notch reporter line expressing a green-to-red, photoconvertible Kaede protein under the control of a Notch-responsive promoter. Photoconversion of Notch-responsive, Kaede^+^ cells in the Dlc/Dld-critical window, before 19.5 hpf (21-ss) yielded converted, red fluorescent progeny that contributed to the region near the dorsal aorta at 3 dpf ([Fig. 4, m, n](#F4){ref-type="fig"}), but these cells never became HSCs, as shown by their failure to produce labelled thymic progeny ([Fig. 4, m′, n′](#F4){ref-type="fig"}). In contrast, photoconversion at 24 hpf and later produced both labelled dorsal aorta ([Fig. 4, o, p](#F4){ref-type="fig"}) and thymic immigrants ([Fig. 4, o′, p′](#F4){ref-type="fig"}). Because there is a lag between reception of a Notch signal and the production of mature Kaede protein in the reporter lines, we wanted to confirm when Notch activity appears in pre-haematopoietic cells by a more immediate read-out for Notch-responsiveness. We performed double in situs, in *tp1:GFP* Notch-reporter transgenic animals, for expression of *GFP* and *etsrp*, which labels pre-haematopoietic mesoderm and is required for HSC specification^[@R27]^. The very first double-labelled cells appeared at 18 hpf in the midline ([Fig. 4, q, r](#F4){ref-type="fig"}), and increased in number through at least 24 hpf ([Fig. 4, s, t](#F4){ref-type="fig"}). Taken together, our data suggest that Notch signalling in cells fated to become HSCs begins after 18 hpf and continues well into the second day of development. This timing fits well with the established model of cell-autonomous Notch specification of HSCs, where Notch signalling in nascent HSCs occurs after aortic specification via interactions between Jag1b and Notch1^[@R1],\ [@R21]-[@R24]^. Overall, our results indicate that somitic signalling by Dlc/Dld downstream of Wnt16 is temporally and spatially distinct from the observable cell-autonomous requirement for Notch signalling. Wnt16 therefore controls a previously unappreciated environmental requirement for Notch signalling in the somites, most simply explained by regulation of an unidentified relay signal.

To better understand what cell population Wnt16-regulated somitic Dlc/Dld acts on, we examined fine somite patterning in Wnt16 and Dlc/Dld loss-of-function animals. Since somite segmentation ([Fig. 2, a, b, e, f](#F2){ref-type="fig"}, [Fig. 3, a-d](#F3){ref-type="fig"}) and myotomal specification ([Fig. 2, e, f](#F2){ref-type="fig"}, [Fig. 3, a-d](#F3){ref-type="fig"}) appear to be intact in *wnt16* morphants, we examined specification of the sclerotomal somite compartment, which houses vertebral and vascular smooth muscle cell (VSMC) precursors. Sclerotomal markers displayed severely decreased expression, albeit to variable extents, in both W16MO and combined *dlc*/*dld* loss of function animals ([Fig. S15; Table S9](#SD1){ref-type="supplementary-material"}). Although hypochord ([Fig. S15, u-y, green arrowheads](#SD1){ref-type="supplementary-material"}), was abolished in the *dlc*/*dld* double loss of function animals ([Fig. S15, x](#SD1){ref-type="supplementary-material"}) as has been reported^[@R18]^, hypochord was specified normally in *wnt16* morphants ([Fig. 2, o, p](#F2){ref-type="fig"}, [Fig. S15, y](#SD1){ref-type="supplementary-material"}), emphasizing the fact that the Wnt16-dependent loss of somitic *dlc*/*dld* is distinct from global loss. Our results suggest that sclerotome specification or morphogenesis is required for HSC specification.

In sum, our results demonstrate that non-canonical signalling by Wnt16 is required genetically upstream of the combined actions of the Notch pathway ligands Dlc and Dld for HSC specification. Dlc/Dld-mediated Notch signalling is spatially and temporally distinct from previously described cell-autonomous requirements for Notch in HSC specification, pointing to the possibility of a novel relay signal. These data represent the first demonstration that non-canonical Wnt signalling activity is required for HSC specification in vertebrates. Given that *Wnt16* in mouse is expressed at similar times of development^[@R28]^ and is expressed in embryoid bodies during commitment to blood and vasculature^[@R29]^, it is feasible that this function is conserved in mammals.
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Zebrafish strains {#S2}
-----------------

The following strains were maintained in accord with IACUC approved procedures: AB\*, *Tg(TOP:GFP)^w25^, Tg(-6.0itga2b:eGFP)^la2^, Tg(hsp70l:Gal4)^1.5kca4^, Tg(UAS:myc-Notch1a-intra)^kca3^, Tg(tp1-MmHbb:EGFP)^um14^, Tg(tp1-MmHbb:Kaede)^um15^, Tg(cmyb:EGFP)^zf169^, Tg(kdrl:RFP)^la4^*, and *dlc^tit446/tit446^*.

Constructs {#S3}
----------

Probes and mRNA were synthesized from published constructs or cloned *de novo* according to standard procedures.

Morpholinos {#S4}
-----------

5 ng W16MO1 AGGTTAGTTCTGTCACCCACCTGTC, W16MO2 GCGTGGAATACTTACATCCAACTTC, W16CoMO AcGTTAGTTgTGTCAgCCAgCTcTC.

Genotyping and PCR {#S5}
------------------

Performed by standard methods using primers and conditions described in the [Complete Methods](#SD8){ref-type="supplementary-material"}.

Whole mount in situ, antibody staining, microscopy {#S6}
--------------------------------------------------

Performed according to standard methods and fully described in the [Complete Methods](#SD8){ref-type="supplementary-material"}.
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![*Wnt16* is required for specification of HSCs\
Expression of the HSC markers *runx1* (a-b) and *cmyb* (c-d). Fluorescently labelled HSCs in *cd41:gfp* (e-f) and *cmyb:GFP;kdrl:RFP* transgenics (g-h). Expression of the lymphocyte marker *rag1* (i-j). Embryos are either uninjected (left column) or injected with 5 ng W16MO (right column). Red arrowheads identify the aorta region (a, c) or individual HSCs (e). Green arrowheads identify unaffected *runx1*^+^ neurons (a-b). Yellow arrowheads identify unaffected GFP^+^ multiciliate cells of the pronephros (e-f). Yellow cells are HSCs (g). Blue arrows identify thymic T cells (i). a-h dorsal up, anterior left. i-j ventral views, anterior up.](nihms313009f1){#F1}

![*Wnt16* loss of function phenotype is specific\
Uninjected or W16MO-injected embryos in brightfield (a-b) or processed by WISH for tissue specific genes: primitive blood (*gata1*, c-d), somites (*myod*, e-f), vasculature (*tll1*, g-h; *cdh5*, i-j; *flk1*, k-l), dorsal aorta (*efnb2a*, m-n), hypochord (*col2a1a*, o-p), floorplate and notochord (*shha*, q-r), or pronephros (*cdh17*, s-t) at the developmental times indicated. Red arrows, dorsal aorta (m-n); green arrows, hypochord (o-p). Anterior left. a-r, dorsal up. s-t, dorsal views.](nihms313009f2){#F2}

![Wnt16 acts upstream of Notch ligands Dlc and Dld\
Expression of somitic *dlc* (a-b) and *dld* (c-d) but not *myod* (red) is decreased at 17 hpf in W16MO-injected embryos. Red bars indicate somites. Expression of the HSC markers *runx1* at 24 hpf (e-h) and *cmyb* at 36 hpf (i-l) is reduced in *dlc* mutant (*bea*) embryos (f, j) or dldMO-injected embryos (g, k), and eliminated in the combined animals (h, l). The lymphocyte marker *rag1* at 4.5 dpf is present in wild-type (m), *bea* (n), and dldMO-injected animals (o), but eliminated in *bea* embryos injected with dldMO (p). Combined injection of *dlc/dld* rescues HSCs in *wnt16* morphants (q-x). *Runx1* at 24 hpf. One group of embryos was uninjected, or injected with the indicated Notch ligand mRNAs alone (q-t). A second group of W16MO-injected embryos was co-injected with Notch ligand mRNAs (u-x). Percentages of embryos displaying the depicted phenotypes (y). a-d flat mounts, anterior left. e-l, q-x close up lateral views, anterior left, dorsal up. m-p ventral head views, anterior up. Red arrowheads indicate the aorta region.](nihms313009f3){#F3}

![Non-cell-autonomous requirement for Notch in HSC specification\
Expression of the Notch target *gata2* (a-b) and the Notch ligand *jag1b* (c-d) in uninjected (a, c) or W16MO-injected (b, d) embryos at 22 hpf. Whole mount immunofluorescence visualization of the myc-tagged NICD at 1 (e-f) and 3 (g-h) hours following either no induction (e, g) or heat-shock induction (f, h). *Cmyb* expression at 36 hpf in transgenic animals carrying a heat-shock inducible dominant activator of Notch signalling (NICD) in uninjected (i), W16MO-injected (j), W16MO-injected and heat-shock induced at 14 hpf (10-ss; k) or 16 hpf (14-ss; l). Red arrowheads indicate the dorsal aorta region. Red circle where HSCs should normally be expressed (h). Green-to-red photoconvertible Kaede Notch reporter animals were entirely photoconverted at the times indicated at left of each panel pair and imaged at 3 dpf (m-p′). Confocal images of the dorsal aorta (white arrowheads; m-p) and thymus (dashed white outline; m′-p′) reveal photoconverted cells only in the thymi of fish converted at 24 and 27 hpf (o′, p′). Max-projection confocal images of the trunk region of embryos processed by double fluorescence in situ for a Notch reporter *GFP* transgene (green) and the haematopoietic mesoderm marker *etsrp* (red) at the times indicated (q-t). Yellow arrowheads indicate double-positive cells (r-t). a-d, i-l close up lateral views of the trunk region, anterior left, dorsal up. e-h, whole embryo views. m-p close up lateral views of the dorsal aorta. m′-p′ single thymic lobes. q-s, dorsal views, anterior left. t, close up lateral aorta view, anterior left, dorsal up.](nihms313009f4){#F4}
